Patents/Assignees

Glaxosmithkline LLC

5 patents in portfolio

US12576089utility2026
Platelet Count-agnostic Methods of Treating Myelofibrosis
0 cites
USRE050497reissue2025
(n-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide
0 cites
USD1042109design2024
Package
0 cites
US11963962utility2024
Platelet Count-agnostic Methods of Treating Myelofibrosis
0 cites
US11643397utility2023
Prolyl Hydroxylase Inhibitors
0 cites